Pathological gambling and hypersexuality in cabergoline-treated prolactinoma

Medical Journal of Australia

Volumn 190, Issue 2, 2009, Pages 97-

  Falhammar, Henrik ^a   Yarker, Jennifer Y ^a  

^a CAIRNS BASE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; PROLACTIN; TESTOSTERONE;

ADULT; CASE REPORT; DISEASE DURATION; DIVORCE; DRUG WITHDRAWAL; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPERSEXUALITY; LETTER; LIBIDO DISORDER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL GAMBLING; PROLACTINOMA; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

EID: 59349119888     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02289.x     Document Type: Letter

References (5)

1. Gallagher DA, O'Sullivan SS, Evans AH, et al. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22: 1757-1763.
2. Avanzi M, Baratti M, Cabrini S, et al. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006; 21: 2068-2072.
3. Davie M. Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. J Neuropsychiatry Clin Neurosci 2007; 19: 473-474.
4. Nyholm D. Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update. Clin Pharmacokinet 2006; 45: 109-136.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.